A recent systematic review and meta-analysis examining the duration of antibiotic prophylaxis for adult stone ureteroscopy (URS) and retrograde intrarenal surgery (RIRS) has concluded that the evidence remains insufficient to determine whether extending prophylactic treatment beyond 24 hours provides a clinical benefit over single-dose or short-course regimens. Infectious complications following these urological procedures can be severe, leading to significant morbidity, yet the optimal duration for preventative antimicrobial therapy has been a subject of ongoing debate. The study aimed to compare single-dose or short-course (≤24 h) with extended (>24 h) prophylactic strategies for adult stone URS/RIRS by synthesizing randomized and observational evidence separately.
To rigorously investigate this comparison, the researchers conducted a systematic search across five major medical databases and a trial registry in June 2026, with supplementary and citation searches extending through October 2026. The study protocol was registered under PROSPERO (CRD420261423763). The primary outcome measure was the incidence of study-defined postoperative infections as reported in the follow-up periods of the identified research.
The findings indicate a high level of uncertainty across the current literature. For the main surgical comparison, nine studies provided the basis for analysis. Five randomised or quasi-randomised trials (420 patients; four informative, 28 events) yielded a risk ratio of 1.01 (95% CI 0.66–1.56; mHK 0.33–3.12).
Complementing the trial data, the analysis of four observational studies involving 1,782 patients resulted in a risk ratio of 0.61, with a 95% confidence interval of 0.24 to 1.55 and mHK intervals of 0.21 to 1.78. While the observational point estimate suggested a lower risk for shorter courses, the confidence intervals remained wide and included the null, and the researchers emphasized that such data remain inherently vulnerable to confounding factors.
The meta-analysis also explored various sensitivity analyses to test the robustness of these findings. A post-hoc cross-design descriptive estimate produced a risk ratio of 0.74 (95% CI 0.47–1.15); however, the authors noted that this analysis deviated from the original study protocol’s registered prohibition on pooling across distinct research designs. Furthermore, a sensitivity analysis specifically focused on clinical-definition outcomes yielded a risk ratio of 0.65 (95% CI 0.38–1.09), while a separate analysis focused on systemic infection outcomes produced a risk ratio of 0.77 (95% CI 0.17–3.50). The authors concluded that precision is sensitive to the interval method.
Beyond the primary comparison, the research team identified five studies that addressed distinct preoperative, cross-phase, or stent-removal prophylactic strategies.
Ultimately, the systematic review concludes that current evidence fails to establish whether extending antibiotic prophylaxis beyond 24 hours improves infection-related outcomes following URS or RIRS, nor does it provide evidence of equivalence between the strategies. The researchers emphasized that the observational associations identified are likely subject to confounding, and the lack of high-risk pooled estimates for the registered primary clinical thresholds limits the applicability of the findings. The study underscores a critical need for future clinical trials to standardize their definitions of infection endpoints and to ensure consistent, long-term surveillance that continues well beyond the point of antibiotic cessation.
Subject of Research: Systematic review and meta-analysis of antibiotic prophylaxis duration for ureteroscopy and retrograde intrarenal surgery.
Article Title: Single-dose or short-course vs. extended antibiotic prophylaxis for ureteroscopy and retrograde intrarenal surgery: a systematic review and meta-analysis
Article References: Cheng, T., Huang, W., Yang, G., Zhang, Z., & Xu, Y. (2026). Single-dose or short-course vs. extended antibiotic prophylaxis for ureteroscopy and retrograde intrarenal surgery: a systematic review and meta-analysis. Frontiers in Medicine, 13, Article 1943166. https://doi.org/10.3389/fmed.2026.1943166
Image Credits: AI Generated
DOI: 10.3389/fmed.2026.1943166
Keywords: Antibiotic Prophylaxis, Ureteroscopy, Retrograde Intrarenal Surgery, Meta-analysis, Systematic Review, Antimicrobial Stewardship, Postoperative Infection, Clinical Guidelines, Medical Research, Urology, Stone Surgery, Prophylactic Strategies, Infectious Complications, Evidence-based Medicine, Healthcare Quality, Treatment Outcomes, Surgery Safety
News Source: Ophelia Keating. (November 18, 2026). Extended Antibiotic Prophylaxis Effectiveness for Ureteroscopy Remains Clinically Uncertain. Scienmag.



